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1. Introduction 
The presence of a number of glycosyl transferases 
in the membranes of rough and smooth microsomes is 
well established [ 11. The core portion of the oligo- 
saccharide chain is attached to dolichol pyrophos- 
phate during synthesis and transferred as a whole to 
the endogenous protein acceptor. Completion of the 
protein-bound oligosaccharide is known to take place 
at various locations. Transfer of individual sugar resi- 
dues from the nucleotide-activated form may or may 
not involve dolichol monophosphate as a lipid inter- 
mediate. 
In liver cells sugar nucleotides are synthesized in 
the cytoplasm, but the majority of the proteins 
synthesized on the endoplasmic reticulum are of the 
secretory type and are glycosylated at the luminal 
surface [2]. On the other hand, protein-bound oligo- 
saccharides are also present at the cytoplasmic surface 
of this organelle and some of the enzymes at this 
surface have now been identified as glycoproteins 
[3-71. One could expect that certain glycosyl trans- 
ferases or at least a part of the glycosyl transferase 
system is present at the cytoplasmic surface of the 
endoplasmic reticulum and, in fact, earlier observa- 
tions indicated that both mannosyl and glucosaminyl 
transferases are sensitive to proteolytic treatment of 
intact microsomal vesicles [8,9]. 
Here, intact, non-permeable rough and smooth 
microsomal vesicles were subjected to proteolysis and 
treated with the non-permeable reagent diazobenzene 
sulfonate (DABS). Inhibitors of glucosyl transferase 
reactions were also employed. The results demonstrate 
that there are several different systems present in the 
endoplasmic reticulum and that a part of them is 
localized at the cytoplasmic surface, especially in 
rough microsomes. 
2. Materials and methods 
Rough and smooth microsomes were prepared as 
in [IO] from livers of adult male rats (180 g). The 
fractions were washed in all experiments by recentrif- 
ugation in 0.15 M Tris-HCl (pH 8.0). p-Diazoben- 
zene sulfonate (DABS) was prepared as in [ 111. The 
incubation mixture contained 50 mM KCl, 50 mM 
Tris-HCl (pH 7.5); 0.25 M sucrose; 0.75 mM DABS 
and 18 mg microsomal protein in 3 ml final vol. The 
incubation time was 2 min in an ice-water bath and 
the process was terminated by adding 5 ml cold 0.25 
M sucrose containing 13 mM CaCl, and 8 mM MgCls 
and centrifuging at 25 000 X g for 15 min. 
For proteolysis the incubation mixture contained 
50 mM KCl; 50 mM Tris-HCl (pH 7.5); 0.25 M 
sucrose; 0.45 mg trypsin (Boehringer, Mannheim); 
0.45 mg unspecific protease (type VII from B. amylo- 
liquefaciens, Sigma, St Louis) and 18 mg microsomal 
protein in 3 ml final vol. The incubation time was 10 
min at 37°C and was terminated by the addition of 
5 ml cold 0.25 M sucrose and centrifugation for 60 
min at 105 000 X g. The incubation mixture for in 
vitro incorporation of mannose contained 30 mM 
Tris-HCl (pH 7.8); 1 mM MnCl,; 2 mM AMP; 0.5 &i 
GDP- [r4C] mannose (80 mCi/mmol. Radiochemical 
Centre, Amersham) and 2.5 mg microsomal protein 
in 1 ml total vol. Amphomycin (400 pg) was added 
where indicated. These incubations were performed 
at 30°C for 30 min. 
When dolichol phosphate (DP)-]14C]mannose was 
used as substrate, the incubation mixture contained 
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30 mM Tris-HCf (pH 7 8); I mM Mm&; 2 mM AMP; 
0.4% Triton X-100; DP-[‘4C]mannose (80 000 cpm) 
and 2.5 mg microsomal protein in 1 ml total vol. 
DP-[14C]mannose was prepared enzymically and puri- 
fied by chromatography. The incubation time was 30 
min at 30°C. Extractions with chloroform-methanol 
(lipid I) and with chloroform-methanol-Hz0 (lipid II) 
were performed as in [8]. The radioactivity in the 
lipid extracts and in the protein pellet was determined 
as in [S]. The incubation mixture for in vitro incorpo- 
ration of ~-acetyl~ucosamine (GlcNAc) contained 30 
mM Tris-HCI (pH 7.8); 2.5 mM EDTA; 10 mM 
MnCl,; 1.5 mM ATP; 1.2 PCi UDP- [ 14C] GlcNAc (300 
mCi/mmol, Radiochemical Centre, Amersham) and 
2.5 mg microsomal protein in 1 ml total vol. Tunica- 
mycin (10 pg) was added where indicated. The incu- 
bation was performed at 30°C for 30 min. When 
dolichol pyrophosphate (DPP)- [““Cl GlcNAc was used 
as substrate, the incubation mixture contained 30 
mM Tris-WC1 (pH 7.8); 2.5 mM EDTA; 10 mM 
MnCla; 1.5 mM ATP; DPP- [ i4C]GlcNAc (80 000 
cpm) and 2.5 mg microsomal protein in 1 ml. DPP- 
]‘4C]GlcNAc was prepared and puri~ed as in [12]. 
Extractions of lipid I and lipid I1 and determination 
of radioactivity of these fractions and of protein were 
also performed as in [S]. Protein was estimated by 
the Biuret procedure [ 131. 
3. Results and discussion 
Investigation of the transverse asymmetry of 
enzymes or enzymic systems in microsomal vesicles 
requires that the permeability barrier of the mem- 
brane is not changed. Microsomal membranes are 
impermeable to both macromolecules and charged 
substances [14]. It is of basic importance to retain 
this impermeability even after proteolysis and DABS 
treatment. When the latency of two enzymes whose 
active sites are localized at the inner surface of the 
microsomal vesicles, namely mannose 6-phosphatase 
and nucleotide diphosphatase, was determined, the 
results were identica! for the treated and untreated 
membranes. In addition, the intramicrosomal water 
determined with dextran of 10 000 &.f, was 1.3 pl/mg 
dry wt in both cases. Therefore, the vesicles used in 
our experiments retained an intact permeability bar- 
rier at the end of the treatment with surface probes. 
Incubation of rough microsomes with GDP-man- 
nose results in incorporation of mannose into the 
lipid I fraction (doiichol monophosphate), the lipid 
II fraction (dolichol pyrophosphate-oligosaccharide) 
and into protein (table I). Amphomycin, which 
is an inhibitor of the interaction of GDP-mannose 
with dolichol phosphate, completely eliminates 
mannose incorporation into lipid I; but incorpora- 
Table 1 
Glycosylation of lipids and proteins of rough and smooth microsomes with GDP-[‘4C]mannose and 
DP-[“‘C]mannose as substrates 
Microsomes, Substrate Inhibitor Lipid I Lipid II Protein 
treatment % of control - 
RM , none GDP-[‘4C]mannose - 100 (2196) 100 (152) 100 (411) 
RM, none GDP-[ 14C]mannose Amphomycin 3 18 54 
RM, DABS GDP-[i4C]mannose - 59 40 58 
RM, proteolysis GDP-[‘4C]mannose - 63 41 54 
RM, proteolysis GDP-[14C]mannose Amphomycin 3 11 39 
RM, none DP-[ “C]mannose - 100 (119) 100 (469) 
RM, DABS DP-[ “‘C!]mannose - 59 63 
SM, none GDP-[t4C]mannose - 100 (909) 100 (83) 100 (471) 
SM , none GDP-[14C]mannose Amphomycin 4 28 97 
SM, DABS GDP-[*4C]mannose - 19 86 94 
SM , none DP-[ “C]mannose - 100 (174) 100 (410) 
SM, DABS DP-[ “C]mannose - 30 45 
~bbrey~~~u~s: RM, rough microsomes; SM, smooth microsomes; DABS, diazobenzene sulfonate; DP, 
dolichol monophosphate 
DABS and proteolytic treatments were performed as in section 2. Where indicated amphomycin (400 
fig/ml) was added to the incubation medium. Lipid I represents the chloroform:methanol(2:1) extract 
and Lipid II the chloroform:methanoI:H,O (1:1:0.3) extract. The values in parenthesis how the 
incorporation in cpm/mg protein taken as 100%. The other values are expressed as the ratio between 
the value obtained in the individual experiment and that of the control 
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tion into protein is still 50% of the original amount. 
When the surface of intact microsomes is attacked 
by DABS or proteases, incorporation into dolichol 
phosphate and into the endogenous protein accep- 
tor are both decreased by 40%. Amphomycin 
further decreases the transfer of mannose into micro- 
somal protein after protease treatment, indicating 
that the dolichol-mediated pathway is present both in 
the protease-insensitive and -sensitive compartments 
of the vesicles. Incubation of rough microsomes with 
DP-mannose also resulted in incorporation both into 
the lipid II and protein fractions and again both of 
these were partially inhibited by DABS treatment. 
The pattern in the case of smooth microsomes i very 
different. Amphomycin eliminates completely the 
transfer of mannose to dolichol phosphate in this 
subfraction; but in contrast o rough microsomes, 
incorporation into protein is not decreased. DABS 
treatment has only a small effect on mannose trans- 
fer to the lipid I fraction and, again, no inhibition of 
incorporation into protein is observed. On the other 
hand, mannose transfer from DP-mannose to DPP- 
oligosaccharide and to protein is inhibited to a large 
extent by DABS-treatment of smooth microsomes. 
Transfer of glucosamine from the nucleotide- 
activated form to dolichol monophosphate is inhibited 
completely by tunicamycin, awell known inhibitor 
of this reaction (table 2). However, about half of the 
protein ~ycosylation was retained. Both DABS and 
proteolytic treatment significantly reduced the incor- 
poration into both lipid fractions and protein. In 
addition, tunicamycin-sensitive glycosylation of pro- 
tein was also present in rough microsomes after pro- 
tease treatment. DABS treatment also reduced the 
transfer of glucosamine from the DPP-bound form to 
the lipid-bound oligosaccharide and to the endogen- 
ous protein acceptor. Tunicamycin eliminates sugar 
transfer to dolichol monophosphate in smooth micro- 
somes as well and the same transfer eaction is strongly 
in~bited by DABS treatment. However, these com- 
pounds had no effect on protein ~ycosylation. On 
the other hand, when DPP-glucosamine is used as sub- 
strate, incorporation into both lipid II fraction and 
protein was strongly reduced. 
This investigation demonstrates that both rough 
and smooth microsomes possess several glycosylating 
pathways, but that the two subfractions differ signifi- 
cantly. The dominating pathway for mannosyl and 
glucosaminyl transfer in rough microsomes involves 
dolichol phosphates. The initial steps are present on 
Table 2 
Glycosylation of lipids and proteins of rough and smooth microsomes with UDP-[‘4C]GlcNAc and 
DPP-[‘*C]GlcNAc as substrates 
Microsomes, 
treatment 
Substrate Inhibitor Lipid I Lipid II 
% of control 
Protein 
RM, none UDP-[t4C]GlcNAc - 100 (1234) 
RM, none UDP-[ “C]GlcNAc Tunicamycin 4 
RM, DABS UDP-[YjGlcNAc - 36 
RM, proteolysis UDP-[‘4C]GI~NA~ - 36 
RM, proteolysis UDP-[ “‘C]GlcNAc Tunicamycin 5 
RM, none DPP-[ 14C JGlcNAc - 
RM, DABS DPP-[‘4C]GlcNAc - 












UDPjz4C]GlcNAc - 100 (962) 
UDP-[“‘C]GlcNAc Tunicamycin 15 
UDP-[ “C]GlcNAc - 49 
DPP-[“‘C]GlcNAc - 
DPP-[ 14C]GlcNAc - 
100 (65) 100 (781) 
27 89 
48 93 
100 (29) 100 (89) 
46 46 
Abbreviations: RM, rough microsomes; SM, smooth microsomes; DABS, diazobenzene sulfonate; 
GlcNAc, N-acetyl-glucosamine; DPP, dolichol pyrophosphate 
DABS and proteolytic treatments were performed as in section 2. Where indicated tunicamycin (10 
ccg/ml) was added to the incubation medium. Lipid I gives the chloroform:methanoi (2:i) and lipid 
II the chloroform:methanol:H~O (1:1:0.3) extract. The values in parenthesis how the incorporation 
in cpm~mg protein taken as 100%. The other values are expressed as the ratio between the value 
obtained in the individual experiment and that of the control 
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the cytoplasmic surface, since they can be inhibited 
by DABS and proteases. On the other hand, the oligo. 
saccharide product is directed to a large extent to the 
inner surface. Judging from the effect of inhibitors 
and proteolytic treatment, it is probable that minor 
glycosylating pathways with and without the involve- 
ment of lipid intermediates are distributed both on 
the outer and inner surfaces of rough microsomes. 
Such transferases or transferase systems could be 
necessary for glycosylation of certain proteins on the 
cytoplasmic surface of the microsomes [3-71. The 
situation with smooth microsomes is very different. 
The main pathway, studied with two substrates, does 
not involve dolichol phosphate. In this case the sugar 
residue is transferred directly to the protein acceptor 
localized in the inner compartment of the smooth 
microsomal membrane which is insensitive to trypsin. 
This particular pathway is probably devoted to the 
completion of certain oligosaccharide chains and is 
not involved in the process of core glycosylation. The 
function of dolichol phosphate in smooth micro- 
somes is not yet clear, but it may be involved in 
minor routes operative in reactions taking place at 
the outer and inner surfaces. The distribution and the 
intramembranous localization of the glycosyl trans- 
ferase systems in rough and smooth microsomes thus 
may be one of the main regulating factors in the 
assembly and transfer of oligosaccharide chains to 
the acceptor endogenous protein. 
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